EBR/FAGR (EBR/FAGR)

Euronext Brussels: EBR/FAGR · EUR

€23.7

-0.20 (-0.8%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	1B
Net income (ttm)	91.7M
EPS (ttm)	€1.25
Shares out	73.3M
P/E (trailing)	18.9x
P/E (forward)	15.6x
Dividend	€0.40 (1.69%)
Volume	83,320
Beta	0.35

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1B
Net income (ttm): 91.7M
EPS (ttm): €1.25
P/E (trailing): 18.9x
P/E (forward): 15.6x
Market cap: 1.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E15.6

P25 n/aP50 n/aP75 n/a

Trailing P/E18.9

P25 n/aP50 n/aP75 n/a

ROE16.7

P25 n/aP50 n/aP75 n/a

ROIC10.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All EBR/FAGR indicators

Market & fundamental data

Available fields

261

Groups with data

Currency

EUR

Showing 261 of 261 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2027-02-11
Employees	4,880
Employees change	687
Employees growth	16.38%
Enterprise value	EUR 2.2B
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1990
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	BE0003874915
Last earnings date	2026-07-30
Last refreshed	2026-10-29
Market cap	EUR 1.7B
Next earnings date	2027-02-11
Price	EUR 23.65
Price currency	EUR
Sector	Healthcare
SIC code	5047
Stock price date	2026-10-29
Symbol	ebr/FAGR
Website	https://www.fagron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	21.38x
Average P/E ratio (3Y)	17.24x
Average P/E ratio (5Y)	17.05x
Earnings yield	5.29%
EV/Earnings	24.64x
EV/EBIT	15.32x
EV/EBITDA	11.87x
EV/FCF	16.6x
EV/Sales	2.2x
FCF / EV yield	6.02%
FCF yield	7.78%
Forward P/E	15.64x
Graham number	15.10047
Graham upside	-37.08%
Lynch fair value	EUR 13.42
Lynch upside	-44.08%
P/(FCF - SBC) ratio	12.94x
P/(OCF - SBC) ratio	10.94x
P/B ratio	2.92x
P/E ratio	18.92x
P/FCF ratio	12.85x
P/OCF ratio	10.87x
P/S ratio	1.7x
Price/EBITDA ratio	10.02x
Sector forward P/E	22.94x
Sector P/E	29.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.35%
EBITDA margin	16.97%
Effective tax rate	20.82%
FCF margin	13.24%
Gross margin	44.4%
Operating margin	14.35%
Pretax margin	11.33%
Profit margin	8.92%
Profit per employee	EUR 18,799
Profitable quarters	18
Profitable years	9
Revenue per employee	EUR 210,762
ROA	6.98%
ROA (5Y)	7.17%
ROCE	11.85%
ROE	16.7%
ROE (5Y)	18.03%
ROIC	10.57%
ROIC (5Y)	12.94%
SBC / revenue	0.1%
Tax / revenue	2.36%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.83%
EPS growth (Q)	1.61%
EPS growth (QoQ)	1.61%
EPS growth 3Y	10.54%
EPS growth 5Y	10.51%
EPS growth quarters	6
EPS growth years	7
FCF growth	28.31%
FCF growth (Q)	-8.76%
FCF growth (QoQ)	-61.09%
FCF growth 3Y	18.73%
FCF growth 5Y	11.37%
Gross profit growth	8.64%
Gross profit growth (Q)	11.32%
Gross profit growth 3Y	13.45%
Gross profit growth 5Y	13.48%
Net income growth	7.06%
Net income growth (Q)	1.57%
Net income growth (QoQ)	1.79%
Net income growth 3Y	10.78%
Net income growth 5Y	10.74%
Net income growth quarters	6
Net income growth years	7
OCF growth	33.62%
OCF growth (Q)	10.77%
OCF growth (QoQ)	-43.48%
OCF growth 10Y	8.18%
OCF growth 3Y	12.13%
OCF growth 5Y	10.64%
Operating income growth	5.77%
Operating income growth (Q)	3.54%
Operating income growth 3Y	14.84%
Operating income growth 5Y	12.18%
Revenue growth	11.95%
Revenue growth (Q)	16.04%
Revenue growth (QoQ)	16.06%
Revenue growth 10Y	9.17%
Revenue growth 3Y	12.27%
Revenue growth 5Y	13.18%
Revenue growth quarters	10
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -24.7M
Depreciation and amortization	EUR 27M
EBIT	EUR 147.6M
EBITDA	EUR 174.6M
EPS	EUR 1.25
FCF per share	EUR 1.86
Financing cash flow	EUR 139M
Free cash flow	EUR 136.2M
Free cash flow minus SBC	EUR 135.2M
Gross profit	EUR 456.6M
Income taxes	EUR 24.3M
Investing cash flow	EUR -249.5M
Net borrowing	EUR 194.9M
Net cash flow	EUR 48.3M
Net income	EUR 91.7M
Operating cash flow minus SBC	EUR 159.9M
Operating income	EUR 147.6M
Revenue	EUR 1B
Stock-based compensation	EUR 990,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.52
Book value per share	EUR 8.11
Debt / EBITDA	3.35
Debt / equity	1.06
Debt / FCF	4.68
Goodwill	EUR 604.4M
Interest coverage	5.54
Long-term assets	EUR 1B
Long-term liabilities	EUR 645.4M
Net cash (debt)	EUR -506.4M
Net cash / market cap	-28.95%
Net debt / EBITDA	2.9
Net debt / equity	0.84
Net debt / FCF	3.72
Piotroski F-Score	5
Property, plant and equipment	EUR 216.4M
Shareholders' equity	EUR 599.6M
Tangible book value	EUR -187.7M
Tangible book value per share	EUR -2.56
Total assets	EUR 1.5B
Total cash	EUR 131.2M
Total debt	EUR 637.6M
Total liabilities	EUR 925.7M
WACC	5.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.78
Current assets	EUR 496.5M
Current liabilities	EUR 280.3M
Current ratio	1.77
Inventory turnover	3.18
Net working capital	EUR 104.3M
Quick ratio	1.02
Working capital	EUR 216.2M
Working capital turnover	5.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.59%
Dividend growth	14.29%
Dividend growth (10Y)	-8.76%
Dividend growth (3Y)	16.96%
Dividend growth (5Y)	17.32%
Dividend growth years	5
Dividend payment date	2026-05-20
Dividend payment years	9
Dividend payout frequency	Annual
Dividend per share	EUR 0.40
Dividend yield	1.69%
Ex-dividend date	2026-05-18
FCF payout ratio	21.55%
Last dividend	EUR 0.40
Payout ratio	39.6%
Shareholder yield	1.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	155.79%
10Y return CAGR	10.64%
10Y total return	174.89%
150-day SMA	EUR 23.25
15Y price change	104.7%
15Y return CAGR	6.49%
15Y total return	156.83%
1D price change	-0.84%
1M price change	3.46%
1M total return	3.46%
1W price change	2.35%
1W total return	2.35%
1Y price change	17.12%
1Y return CAGR	18.49%
1Y total return	18.48%
20-day SMA	EUR 23.05
200-day SMA	EUR 22.99
3M price change	2.79%
3M total return	2.79%
3Y price change	46.48%
3Y return CAGR	14.87%
3Y total return	51.6%
50-day SMA	EUR 22.46
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 25.30
52-week high date	2026-05-27
52-week low	EUR 20.00
52-week low date	2025-12-09
5Y price change	58.4%
5Y return CAGR	10.8%
5Y total return	67.01%
6M price change	0.84%
6M total return	2.02%
All-time high	EUR 44.98
All-time high date	2014-08-05
All-time low	EUR 3.70
All-time low date	2015-12-14
Average true range (ATR)	EUR 0.46
Average volume	112K
Beta (1Y)	0.64
Beta (2Y)	0.52
Beta (5Y)	0.35
Change from 52-week high	-6.52%
Change from 52-week low	18.25%
Change from all-time high	-46.75%
Change from all-time low	547.65%
Change from open	-0.42%
Day's gap	-0.42%
Dollar volume	EUR 2M
High price	EUR 24.08
Low price	EUR 23.65
Monthly RSI	62.32
Open price	EUR 23.75
Position in 52-week range	0%
Previous close	EUR 23.85
Price vs 150-day SMA	3.02%
Price vs 20-day SMA	3.9%
Price vs 200-day SMA	4.18%
Price vs 50-day SMA	6.63%
Relative volume	0.74
RSI	63.73
Sharpe ratio	0.73
Sharpe ratio (3Y)	0.53
Sharpe ratio (5Y)	0.48
Sortino ratio	1.48
Sortino ratio (3Y)	1.11
Sortino ratio (5Y)	0.96
Volume	83.3K
Weekly RSI	58.01
YTD price change	12.44%
YTD total return	13.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	65.9M
Shares change (QoQ)	0.24%
Shares change (YoY)	0.59%
Shares held by insiders	0.3%
Shares held by institutions	54.17%
Shares outstanding	73.3M

Deeper analysis on EBR/FAGR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this EBR/FAGR report

Is a complete EBR/FAGR research report available?

No complete published report is available for ebr/FAGR (EBR/FAGR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

1.7B

Revenue (ttm)

Net income (ttm)

91.7M

EPS (ttm)

€1.25

Shares out

73.3M

P/E (trailing)

18.9x

P/E (forward)

15.6x

Dividend

€0.40 (1.69%)

Volume

83,320

Beta

0.35

Metric

Value

Amount currency

EUR

Country

Belgium

Country code

Earnings date

2027-02-11

Employees

4,880

Employees change

687

Employees growth

16.38%

Enterprise value

EUR 2.2B

Exchange

Euronext Brussels

Financial currency

EUR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1990

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

ISIN number

BE0003874915

Last earnings date

2026-07-30

Last refreshed

2026-10-29

Market cap

EUR 1.7B

Next earnings date

2027-02-11

Price

EUR 23.65

Price currency

EUR

Sector

Healthcare

SIC code

5047

Stock price date

2026-10-29

Symbol

ebr/FAGR

Website

https://www.fagron.com

Metric

Value

Average P/E ratio (10Y)

21.38x

Average P/E ratio (3Y)

17.24x

Average P/E ratio (5Y)

17.05x

Earnings yield

5.29%

EV/Earnings

24.64x

EV/EBIT

15.32x

EV/EBITDA

11.87x

EV/FCF

16.6x

EV/Sales

2.2x

FCF / EV yield

6.02%

FCF yield

7.78%

Forward P/E

15.64x

Graham number

15.10047

Graham upside

-37.08%

Lynch fair value

EUR 13.42

Lynch upside

-44.08%

P/(FCF - SBC) ratio

12.94x

P/(OCF - SBC) ratio

10.94x

P/B ratio

2.92x

P/E ratio

18.92x

P/FCF ratio

12.85x

P/OCF ratio

10.87x

P/S ratio

1.7x

Price/EBITDA ratio

10.02x

Sector forward P/E

22.94x

Sector P/E

29.62x

Metric

Value

EBIT margin

14.35%

EBITDA margin

16.97%

Effective tax rate

20.82%

FCF margin

13.24%

Gross margin

44.4%

Operating margin

14.35%

Pretax margin

11.33%

Profit margin

8.92%

Profit per employee

EUR 18,799

Profitable quarters

Profitable years

Revenue per employee

EUR 210,762

ROA

6.98%

ROA (5Y)

7.17%

ROCE

11.85%

ROE

16.7%

ROE (5Y)

18.03%

ROIC

10.57%

ROIC (5Y)

12.94%

SBC / revenue

0.1%

Tax / revenue

2.36%

Metric

Value

EPS growth

6.83%

EPS growth (Q)

1.61%

EPS growth (QoQ)

1.61%

EPS growth 3Y

10.54%

EPS growth 5Y

10.51%

EPS growth quarters

EPS growth years

FCF growth

28.31%

FCF growth (Q)

-8.76%

FCF growth (QoQ)

-61.09%

FCF growth 3Y

18.73%

FCF growth 5Y

11.37%

Gross profit growth

8.64%

Gross profit growth (Q)

11.32%

Gross profit growth 3Y

13.45%

Gross profit growth 5Y

13.48%

Net income growth

7.06%

Net income growth (Q)

1.57%

Net income growth (QoQ)

1.79%

Net income growth 3Y

10.78%

Net income growth 5Y

10.74%

Net income growth quarters

Net income growth years

OCF growth

33.62%

OCF growth (Q)

10.77%

OCF growth (QoQ)

-43.48%

OCF growth 10Y

8.18%

OCF growth 3Y

12.13%

OCF growth 5Y

10.64%

Operating income growth

5.77%

Operating income growth (Q)

3.54%

Operating income growth 3Y

14.84%

Operating income growth 5Y

12.18%

Revenue growth

11.95%

Revenue growth (Q)

16.04%

Revenue growth (QoQ)

16.06%

Revenue growth 10Y

9.17%

Revenue growth 3Y

12.27%

Revenue growth 5Y

13.18%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -24.7M

Depreciation and amortization

EUR 27M

EBIT

EUR 147.6M

EBITDA

EUR 174.6M

EPS

EUR 1.25

FCF per share

EUR 1.86

Financing cash flow

EUR 139M

Free cash flow

EUR 136.2M

Free cash flow minus SBC

EUR 135.2M

Gross profit

EUR 456.6M

Income taxes

EUR 24.3M

Investing cash flow

EUR -249.5M

Net borrowing

EUR 194.9M

Net cash flow

EUR 48.3M

Net income

EUR 91.7M

Operating cash flow minus SBC

EUR 159.9M

Operating income

EUR 147.6M

Revenue

EUR 1B

Stock-based compensation

EUR 990,000

Metric

Value

Altman Z-Score

2.52

Book value per share

EUR 8.11

Debt / EBITDA

3.35

Debt / equity

1.06

Debt / FCF

4.68

Goodwill

EUR 604.4M

Interest coverage

5.54

Long-term assets

EUR 1B

Long-term liabilities

EUR 645.4M

Net cash (debt)

EUR -506.4M

Net cash / market cap

-28.95%

Net debt / EBITDA

2.9

Net debt / equity

0.84

Net debt / FCF

3.72

Piotroski F-Score

Property, plant and equipment

EUR 216.4M

Shareholders' equity

EUR 599.6M

Tangible book value

EUR -187.7M

Tangible book value per share

EUR -2.56

Total assets

EUR 1.5B

Total cash

EUR 131.2M

Total debt

EUR 637.6M

Total liabilities

EUR 925.7M

WACC

5.39%

Metric

Value

Asset turnover

0.78

Current assets

EUR 496.5M

Current liabilities

EUR 280.3M

Current ratio

1.77

Inventory turnover

3.18

Net working capital

EUR 104.3M

Quick ratio

1.02

Working capital

EUR 216.2M

Working capital turnover

5.45

Metric

Value

Buyback yield / dilution

-0.59%

Dividend growth

14.29%

Dividend growth (10Y)

-8.76%

Dividend growth (3Y)

16.96%

Dividend growth (5Y)

17.32%

Dividend growth years

Dividend payment date

2026-05-20

Dividend payment years

Dividend payout frequency

Annual

Dividend per share

EUR 0.40

Dividend yield

1.69%

Ex-dividend date

2026-05-18

FCF payout ratio

21.55%

Last dividend

EUR 0.40

Payout ratio

39.6%

Shareholder yield

1.07%

Metric

Value

10Y price change

155.79%

10Y return CAGR

10.64%

10Y total return

174.89%

150-day SMA

EUR 23.25

15Y price change

104.7%

15Y return CAGR

6.49%

15Y total return

156.83%

1D price change

-0.84%

1M price change

3.46%

1M total return

3.46%

1W price change

2.35%

1W total return

2.35%

1Y price change

17.12%

1Y return CAGR

18.49%

1Y total return

18.48%

20-day SMA

EUR 23.05

200-day SMA

EUR 22.99

3M price change

2.79%

3M total return

2.79%

3Y price change

46.48%

3Y return CAGR

14.87%

3Y total return

51.6%

50-day SMA

EUR 22.46

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 25.30

52-week high date

2026-05-27

52-week low

EUR 20.00

52-week low date

2025-12-09

5Y price change

58.4%

5Y return CAGR

10.8%

5Y total return

67.01%

6M price change

0.84%

6M total return

2.02%

All-time high

EUR 44.98

All-time high date

2014-08-05

All-time low

EUR 3.70

All-time low date

2015-12-14

Average true range (ATR)

EUR 0.46

Average volume

112K

Beta (1Y)

0.64

Beta (2Y)

0.52

Beta (5Y)

0.35

Change from 52-week high

-6.52%

Change from 52-week low

18.25%

Change from all-time high

-46.75%

Change from all-time low

547.65%

Change from open

-0.42%

Day's gap

-0.42%

Dollar volume

EUR 2M

High price

EUR 24.08

Low price

EUR 23.65

Monthly RSI

62.32

Open price

EUR 23.75

Position in 52-week range

Previous close

EUR 23.85

Price vs 150-day SMA

3.02%

Price vs 20-day SMA

3.9%

Price vs 200-day SMA

4.18%

Price vs 50-day SMA

6.63%

Relative volume

0.74

RSI

63.73

Sharpe ratio

0.73

Sharpe ratio (3Y)

0.53

Sharpe ratio (5Y)

0.48

Sortino ratio

1.48

Sortino ratio (3Y)

1.11

Sortino ratio (5Y)

0.96

Volume

83.3K

Weekly RSI

58.01

YTD price change

12.44%

YTD total return

13.75%

Metric

Value

Float

65.9M

Shares change (QoQ)

0.24%

Shares change (YoY)

0.59%

Shares held by insiders

0.3%

Shares held by institutions

54.17%

Shares outstanding

73.3M

EBR/FAGR (EBR/FAGR)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/FAGR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/FAGR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/FAGR

Frequently asked questions

EBR/FAGR (EBR/FAGR)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/FAGR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/FAGR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/FAGR

Frequently asked questions